Mitchell D. Schnall, MD, PhD
Group Co-Chair

Dr. Schnall is the Group Co-Chair of the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) since the founding of the Group in 2012. He co-leads the organizationโ€™s governance and is a member of several scientific committees. He oversees the Tomosynthesis Mammographic Imaging Screening Trial (TMIST) and significantly influences the Group's research into emerging imaging technologies. He is Secretary/Treasurer of the ECOG-ACRIN Medical Research Foundation.

Dr. Schnall is the Senior Vice President for Data and Technology Solutions for the University of Pennsylvania Health System in Philadelphia, since 2024, following two terms as Chair of the Department of Radiology at the Perelman School of Medicine, where he is the Eugene P. Pendergrass Professor of Radiology. He is a physician at Penn Medicine within its Abdominal Imaging Services program.

Dr. Schnall was one of the architects of the merger that formed ECOG-ACRIN in 2012. He was the Deputy Chair of the American College of Radiology Imaging Network (ACRIN) when the network was founded in 1999. He was elected Group Chair of ACRIN in 2008. Before merging with the Eastern Cooperative Oncology Group (ECOG) in 2012 to form the ECOG-ACRIN Cancer Research Group, ACRIN was a National Cancer Institute (NCI)-sponsored cancer cooperative group that designed, conducted, and reported on multicenter clinical trials of imaging in cancer and conducted similar research in neurology and cardiovascular through non-NCI funding. Notable among the multiple clinical studies under his direction at ACRIN were the National Lung Screening Trial (NLST), the Digital Mammography Imaging Screening Trial (DMIST), and the National CT Colonography Trial.

He received his undergraduate, medical, and doctorate degrees from the University of Pennsylvania.

ECOG-ACRIN Cancer Research Group